Clinolipid Injection, Emulsion
Product Images NDC 0338-9540

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clinolipid (NDC 0338-9540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula 1 (Image 01)

Structural Formula 1 (Image 01)
The text describes a chemical formula or structure with various symbols and letters representing saturated and unsaturated fatty residues.*
FDA Label Image

Structural Formula 2 (Image 02)

Structural Formula 2 (Image 02)
Linoleic acid, Oleic acid, Palmitic acid, Linolenic acid, Palmitoleic acid and Stearic acid are listed with their respective chemical formulas.*
FDA Label Image

Clinolipid Representative Container Label (Image 03)

Clinolipid Representative Container Label (Image 03)
Clinolipid is an intravenous-use-only lipid injectable emulsion, in a sterile single 1000 mL container with an energy content of 2000 kcal/L by Baxter. Each 100 mL contains about 16 g of Olive Oil NF, 4 g of Soybean Oil USP, 1.2 g Egg Phospholipids NF, 2.25 g Glycerin USP, 0.03 g Sodium Oleate, Water for Injection USP, and Sodium Hydroxide NF for pH adjustment pH 6.0 - 9.0, with osmolarity 260 mOsmol/L. The clinical use of Clinolipid requires checking the oxygen indicator's color for the allowable range and homogeneous milky appearance after mixing. Dosage should be according to the package insert. Clinolipid must not be used with supplemental medication, series connections, or beyond 24 hours of the opening. It should be stored between 20 to 25 °C with excursions permitted between 15 to 30 °C, according to USP controlled room temperature. BE-35-02-746 is the lot number of Clinolipid produced by Baxter Healthcare Corporation.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.